Dark Forest Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$916K Sell
10,624
-10,955
-51% -$984K 0.07% 500
2026
Q2
$2.06M Buy
21,579
+18,167
+532% +$1.65M 0.13% 276
2026
Q1
$328K Buy
+3,412
New +$341K 0.03% 652
2023
Q2
– Sell
-1,510
Closed -$59.4K – 1214
2023
Q1
$59.4K Buy
+1,510
New +$54.9K 0.01% 806

Other funds holding IRMD

Dark Forest Capital Management's IRMD Position: Q3 2026 in Review

Dark Forest Capital Management reduced its iRadimed (IRMD) stake by 51% in Q3 2026, selling an estimated $984K and leaving 10,624 shares worth $916K. The position accounts for 0.07% of the portfolio, ranked #500.

Dark Forest Capital Management first reported a position in IRMD in Q1 2023 and has held it in 4 quarters since. The position peaked at $2.06M in Q2 2026. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Dark Forest Capital Management held 10,624 shares of iRadimed worth $916K as of Q3 2026.
  • Dark Forest Capital Management sold 10,955 iRadimed shares in Q3 2026, an estimated $984K.
  • iRadimed made up 0.07% of Dark Forest Capital Management's portfolio in Q3 2026, its #500 holding.
  • Dark Forest Capital Management first reported a position in iRadimed in Q1 2023 and has held it in 4 quarters since.
  • Dark Forest Capital Management's iRadimed position peaked at $2.06M in Q2 2026.
  • 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Dark Forest Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.